DISCOUNTINUED OPERATIONS (Tables)

9 Months Ended

Sep. 30, 2022

Unaudited Condensed Consolidated Statements of Operations

Schedule of net cash received from the Asset Sale

Sales price	$	20,000
Forgiveness of Buyer advances		(4,150	)
Holdback secured by promissory note		(2,000	)
Obligations assumed by Buyer		(41	)
Buyer expenses paid by seller		82
Net cash received	$	13,891

Schedule of net loss incurred from the Asset Sale

Sales price for assets sold	$	20,000
Net book value of assets sold		20,616
Net book value of liabilities sold		(51	)
Net book value of net assets sold		20,565
Loss on sale of net assets	$	(565	)

Schedule of aggregate carrying amounts of assets and liabilities held for sale

	December 31,
	2021
Carrying amounts of assets included as part of assets held for sale:
Inventory, net	$	243
Prepaid expenses and other assets		97
Property and equipment, net		1,837
Finance lease right-of-use assets, net		40
Goodwill, net		9,178
Intellectual property and patents, net		14,401
In-process research and development, net		329
Other assets		35
Total assets classified as assets held for sale in the unaudited condensed consolidated balance sheet	$	26,160
Carrying amounts of liabilities included as part of liabilities held for sale:
Accrued expenses	$	268
Finance lease payable		40
Contract liabilities		215
Total liabilities classified as liabilities held for sale in the unaudited condensed consolidated balance sheet	$	523

Schedule of financial results of the pharmaceutical segment

	For the Three Months Ended						For the Nine Months Ended
	September 30, 2022			September 30, 2021			September 30, 2022			September 30, 2021
Revenue:
Product sales, net of discounts and refunds	$	-		$	16		$	108		$	151
Consulting research & development income		-			-			58			52
Shipping and other sales		-			18			40			57
Total revenue		-			34			206			260
Cost of goods sold:
Cost of goods sold		-			75			75			256
Gross profit		-			(41	)		131			4
Operating expenses:
Research and development expenses		28			601			492			1,944
Selling, general and administrative expenses		91			394			1,313			743
Loss on disposition		565			-			565			-
Impairment of goodwill		-			-			4,728			-
Total operating expenses		684			995			6,533			2,687
Net loss before income taxes		(684	)		(1,036	)		(6,967	)		(2,683	)
Provision for income taxes		-			-			-			-
Net loss	$	(684	)	$	(1,036	)	$	(6,402	)	$	(2,683	)